![]()
|
|
||||||||
(Received for publication, August 15, 1996, and in revised form, October 22, 1996)
From the Yeast Rox3 protein, implicated by genetic
evidence in both negative and positive transcriptional regulation, is
identified as a mediator subunit by peptide sequence determination and
is shown to copurify and co-immunoprecipitate with RNA polymerase II
holoenzyme.
Transcription reconstituted with a set of pure general
transcription factors and RNA polymerase II from the yeast
Saccharomyces cerevisiae is unresponsive to activator
proteins (1). Addition of a multiprotein complex termed mediator
enables a response to activators and also stimulates both basal
transcription and phosphorylation of the C-terminal domain of the
polymerase (1). Mediator interacts with the C-terminal domain, forming
a polymerase holoenzyme, whose existence first came to light from
genetic studies of the Srb family of proteins and their isolation in a
complex with polymerase II (2). Srbs were subsequently identified as
subunits of mediator, along with about a dozen additional polypeptides
(1). Current work is directed toward the nature of these polypeptides
and their roles in transcription in vitro and in
vivo.
Three mediator polypeptides have been identified as products of the
GAL11, SIN4, and RGR1 genes,
previously recovered from disparate genetic screens for mutations
affecting transcription (3, 4, 5). The SIN4 and RGR1
screens were for loss of repression, pointing to a role of mediator in
negative regulation of transcription. It has since emerged that Gal11,
Sin4, and Rgr1 all participate in control of the same large family of
genes and that they are involved in both activation and repression
(6, 7, 8, 9). Consistent with the genetic findings, Gal11, Sin4, and Rgr1
appear to interact in a subassembly of the mediator complex (10). These
studies, together with effects of srb mutations on
INO1 gene expression (11), provide evidence for a role of mediator in transcriptional regulation in vivo.
Mediator polypeptides in addition to Srbs and the Gal11 subassembly
have been designated Med1-Med8 (12). Elsewhere we and others describe
the isolation and characterization of MED6, a novel gene
important for inducible transcription and required for yeast cell
growth.1, 2 Here we report
on Med8 which, like the members of the Gal11 subassembly, proves to be
the product of a gene previously characterized as important for
transcriptional regulation in vivo.
Purification of RNA polymerase II
holoenzyme from the hemagglutinin antigen-tagged Rox3 strain was as
described (12).
Peptides were generated from the
PVDF3-bound, 31-kDa protein by tryptic
digestion in situ (13, 14) and were fractionated by reversed
phase HPLC (15) with the use of a 1-mm Reliasil C18 column. Selected
peak fractions were analyzed by a combination of automated Edman
chemical degradation (16) and matrix-assisted laser desorption
ionization time-of-flight mass spectrometry (13, 17). Peptide sequences
were compared with entries in the Saccharomyces Genome Data base (SGD,
Stanford Genomic Resources, Stanford University) with the use of the
National Center for Biotechnology Information (NCBI) BLAST program
(18). Experimental masses of these and additional peptides were
compared with the theoretical average isotopic masses of fragments
expected to result from tryptic digestion of the identified proteins
(with the use of PeptideSearch software; Dr. Matthias Mann, EMBL,
Heidelberg, Germany).
The 3 Anti-Med6 antibodies were coupled to
protein A-Sepharose beads and used to immunoprecipitate purified Rox3HA
holopolymerase as described (10) with the following modifications.
Subsequent to coupling and prior to incubation with Rox3HA
holopolymerase fraction, 50 µl of anti-Med6 beads were washed with
100 µl of a buffer containing 50 mM glycine, pH 2.3, 150 mM NaCl, followed by several washes with 100 µl of IP-200
buffer (20 mM HEPES, pH 7.6, 10% glycerol, 12.5 mM MgCl2, 0.1 mM EDTA, 0.2%
Nonidet P-40, 0.1 mM dithiothreitol, 200 mM
potassium acetate). Rox3HA holopolymerase Mono Q fraction 50 (10 µl)
was diluted with 40 µl of buffer Q, 0.5 (25 mM Tris
acetate, pH 7.8, 10% glycerol, 1 mM EDTA, 0.5 M potassium acetate) and sedimented for 5 min at 13,000 rpm
prior to incubation with the beads. Following incubation with the
diluted fraction for 4 h at 4 °C, the beads were washed three
times with 200 µl of IP-200 buffer and eluted twice for 10 min at
room temperature with 17.5 µl of 5 M urea. To the
combined eluates was added 20 µl of 2 × SDS loading buffer
(20% glycerol, 10% 2-mercaptoethanol, 4.6% SDS, 125 mM
Tris-Cl, pH 6.8, 0.1% (w/v) bromphenol blue) for SDS-PAGE and
immunoblotting.
The occurrence of Rox3 in mediator preparations was revealed by
peptide sequencing. Mediator polypeptides were resolved by SDS-PAGE and
transferred to a PVDF membrane. A band just below the 31-kDa marker,
designated Med8 (12), was excised and subjected to tryptic digestion.
The partial sequence of one fragment, SYPSEFANQNQGGAQAPFDIDDLAF, corresponded identically with residues 148-172 of the amino acid sequence expected from the ROX3 gene. The experimental mass
of this peptide was in good agreement (within 0.01% of) the
theoretical average isotopic mass of the expected tryptic peptide
containing the partial sequence. Mass analyses allowed accurate
positioning of several more tryptic peptides in the Rox3 protein
sequence.
The occurrence of Rox3 in RNA polymerase II holoenzyme was confirmed by
copurification and co-immunoprecipitation. A derivative of the
ROX3 gene, denoted ROX3HA, was constructed for
expression of the protein with three copies of the influenza virus
hemagglutinin antigen appended to the C terminus. ROX3HA was
able to replace ROX3, so it evidently supplies all the
essential functions of the wild type gene.4
RNA polymerase II holoenzyme was purified from a ROX3HA
strain by chromatography on Bio-Rex 70, DEAE-Sephacel,
hydroxylapatite, and Mono Q, followed by gel filtration through
Bio-Sil SEC 400, as described (12). The gel filtration step was
performed at high ionic strength to minimize nonspecific
protein-protein interactions. Immunoblots revealed comigration of
epitope-tagged Rox3 with holoenzyme components Rpb1, Gal11, and Srb4 on
both Mono Q and Bio-Sil SEC 400 (Fig. 1, A
and B).
Immunoprecipition was performed with antibodies against the Med6
component of mediator/holoenzyme coupled to protein A-Sepharose. Incubation of holopolymerase with the antibody-Sepharose and subsequent washing steps were performed under stringent conditions. Immunoblot analyses demonstrated that Rox3HA and holoenzyme components Srb4, Rpb1,
and Rpb3 were almost entirely bound by the antibody beads (Fig.
2). We conclude that all Rox3 in the holopolymerase
preparation was associated with holoenzyme.
The reciprocal co-immunoprecipitation experiment was performed with
antibodies against the influenza hemagglutinin antigen of Rox3HA.
SDS-PAGE and silver staining showed that RNA polymerase II holoenzyme
was bound by the antibody beads (data not shown), though the extent of
binding was not determined.
The relative amount of Rox3 in RNA polymerase II holoenzyme was
estimated from the A214 of tryptic peptides
resolved by HPLC and by SDS-PAGE, staining with Coomassie Blue, and
densitometry. The intensity of staining of the Med8/Rox3 band, relative
to those of the other mediator/holoenzyme components Gal11, Rgr1, Med1, Med7, and Srb7, was consistent with expectation. We conclude that Rox3
is stoichiometric with other components of mediator/holoenzyme.
The results presented here demonstrate the occurrence of Rox3 in
mediator and RNA polymerase II holoenzyme. Immunoprecipitation experiments and quantitation establish that Rox3 is an integral rather
than a trace or substoichiometric component of holoenzyme preparations.
Genetic studies indicate that the association of Rox3 with
mediator/holoenzyme is physiologically relevant and not an artifact of
biochemical isolation. The ROX3 gene was originally found in
a search for mutants leading to overexpression of the heme-regulated
CYC7 gene (21). ROX3 proved to be essential for cell growth, and Rox3 protein was shown to be nuclear localized. ROX3 was later identified as SSN7 (22), derived
from a screen for mutants bypassing the requirement for Snf1 protein
kinase for expression of glucose-repressed genes (23). ROX3
is also synonymous with RMR1, whose mutation can relieve
glucose repression of the CYB2 gene (24). Finally,
ROX3 is needed for full induction of the GAL1
gene in the presence of galactose (24). And Rox3 fused to the
DNA-binding domain of lexA stimulates transcription from a promoter
with a lexA-binding site (22). ROX3 therefore plays a role
in both repression and activation of transcription.
In its dual regulatory capacity, Rox3 resembles the previously
described mediator proteins Gal11, Sin4, and Rgr1 (see Introduction). Like Rox3, these proteins first came to light from genetic screens unconnected with RNA polymerase II. Their subsequent identification as
components of mediator/holoenzyme, together with that of Rox3, provides
the strongest evidence to date for a role of mediator in
transcriptional regulation in vivo.
Through its involvement in transcription of the CYC7 gene,
induced under all forms of cellular stress (25, 26, 27), Rox3 contributes
to the global stress response. Truncation of Rox3 diminishes the
CYC7 response to heat shock and osmotic stress, and deletion
of RTS1, a multicopy supressor of mutations in
ROX3, causes a similar phenotype (25). RTS1
encodes a cytoplasmic protein highly homologous to the B
Volume 272, Number 1,
Issue of January 3, 1997
pp. 48-50
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
COMMUNICATION:
§¶,
§
,
**,
,
Department of Structural Biology, Stanford
University School of Medicine, Stanford, California 94305-5400, the

Department of Biochemistry and Biophysics,
University of California San Francisco, California 94143-0502, and the
§§ Molecular Biology Program, Memorial
Sloan-Kettering Cancer Center, New York, New York 10021
Protein Purification
-end (240 base pairs) of the ROX3 gene
was amplified by polymerase chain reaction and ligated in frame with
the hemagglutinin tags of pMR46, a derivative of Yplac111
CEN ARS LEU2 in which CEN and ARS have been deleted and
three copies of the hemagglutinin tag (HA-tag) have been inserted in
the polylinker (19). The resulting plasmid was digested with
XbaI and transformed into Saccharomyces
cerevisiae BJ5459 (MATa ura3-52 trp1 lys2-801 leu2-D1 his3 D200 pep4::HIS3 prb1 D1.6R can1) (20).
Integration at the ROX3 locus resulted in a
hemagglutinin-tagged full-length copy of the gene and another partial
copy consisting of the 3
-most 240 base pairs of the gene with no
promoter.
Fig. 1.
Copurification of hemagglutinin
antigen-tagged Rox3 with RNA polymerase II holoenzyme. A,
comigration of Rpb1, Srb4, and Rox3 on Mono Q. Fractions around the
peak of holopolymerase (750 mM potassium acetate) were
analyzed by immunoblotting with antisera against Rpb1, Srb4, and the
hemagglutinin antigen. B, comigration of Srb4, Gal11, and
Rox3 on Bio-Sil SEC 400. Fractions were analyzed by immunoblotting with
antisera against Srb4, Gal11, and the hemagglutinin antigen.
[View Larger Version of this Image (35K GIF file)]
Fig. 2.
Co-immunoprecipitation of Gal11, Srb4, Rpb3,
and Rox3HA from Mono Q fraction 50 by anti-Med6 antibody coupled to
protein A-Sepharose. Bands from the immunoprecipitate (pellet) are weaker than from the starting fraction (load) due to loss of
holopolymerase under the stringent washing conditions.
[View Larger Version of this Image (24K GIF file)]
-subunit of
human protein phosphatase 2A, which is involved in several
intracellular signaling pathways (28). It has been suggested that Rts1
is part of such a pathway, affecting gene expression in response to
stress (25). The genetic relationship between RTS1 and
ROX3 raises the possibility of mediator/holoenzyme as an end
point of this pathway.
*
This work was supported in part by National Institutes of
Health Grant GM36659 (to R. D. K), by National Science Foundation Grant
BIR-940123 (to P. T.), by National Cancer Institute Core Grant 5 P30
CA08748 to the Sloan-Kettering Sequencing Laboratory, and by National
Institutes of Health Grant GM37049-10 (to A. D. Johnson). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶
Recipient of a Swedish Cancer Society postdoctoral
fellowship.
Supported by Cancer Research Fund of the Damon Runyon-Walter
Winchell Foundation Fellowship DRG-1361.
**
Supported by a Bank of America-Giannini Foundation Fellowship for
medical research in California.
1
Y. Li, S. Bjorklund, Y.-J. Kim, W. Lane, and R. D. Kornberg, submitted for publication.
2
Y.-C. Lee, S. Min, B. S. Gim, and Y.-J. Kim,
submitted for publication.
3
The abbreviations used are: PVDF, polyvinylidene
difluoride; HPLC, high performance liquid chromatography; PAGE,
polyacrylamide gel electrophoresis.
4
M. J. Redd and A. D. Johnson, unpublished
observations.
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. M. Baidoobonso, B. W. Guidi, and L. C. Myers Med19(Rox3) Regulates Intermodule Interactions in the Saccharomyces cerevisiae Mediator Complex J. Biol. Chem., February 23, 2007; 282(8): 5551 - 5559. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Koffel and R. Schneiter Yeh1 Constitutes the Major Steryl Ester Hydrolase under Heme-Deficient Conditions in Saccharomyces cerevisiae. Eukaryot. Cell, July 1, 2006; 5(7): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takagi and R. D. Kornberg Mediator as a General Transcription Factor J. Biol. Chem., January 6, 2006; 281(1): 80 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gulshan, S. A. Rovinsky, S. T. Coleman, and W. S. Moye-Rowley Oxidant-specific Folding of Yap1p Regulates Both Transcriptional Activation and Nuclear Localization J. Biol. Chem., December 9, 2005; 280(49): 40524 - 40533. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Malagon, A. H. Tong, B. K. Shafer, and J. N. Strathern Genetic Interactions of DST1 in Saccharomyces cerevisiae Suggest a Role of TFIIS in the Initiation-Elongation Transition Genetics, March 1, 2004; 166(3): 1215 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Lewis and D. Reinberg The mediator coactivator complex: functional and physical roles in transcriptional regulation J. Cell Sci., September 15, 2003; 116(18): 3667 - 3675. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Balciunas, M. Hallberg, S. Bjorklund, and H. Ronne Functional Interactions within Yeast Mediator and Evidence of Differential Subunit Modifications J. Biol. Chem., January 31, 2003; 278(6): 3831 - 3839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sheffer, M. Varon, and M. Choder Rpb7 Can Interact with RNA Polymerase II and Support Transcription during Some Stresses Independently of Rpb4 Mol. Cell. Biol., April 1, 1999; 19(4): 2672 - 2680. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Lee, J. M. Park, S. Min, S. J. Han, and Y.-J. Kim An Activator Binding Module of Yeast RNA Polymerase II Holoenzyme Mol. Cell. Biol., April 1, 1999; 19(4): 2967 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sartori, L. Aldegheri, G. Mazzotta, G. Lanfranchi, H. Tournu, A. J. P. Brown, and G. Carignani Characterization of a New Hemoprotein in the Yeast Saccharomyces cerevisiae J. Biol. Chem., February 19, 1999; 274(8): 5032 - 5037. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiao, Y. Tao, and R. G. Roeder The Human Homologue of Drosophila TRF-proximal Protein Is Associated with an RNA Polymerase II-SRB Complex J. Biol. Chem., February 12, 1999; 274(7): 3937 - 3940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Han, Y. C. Lee, B. S. Gim, G.-H. Ryu, S. J. Park, W. S. Lane, and Y.-J. Kim Activator-Specific Requirement of Yeast Mediator Proteins for RNA Polymerase II Transcriptional Activation Mol. Cell. Biol., February 1, 1999; 19(2): 979 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Balciunas, C. Galman, H. Ronne, and S. Bjorklund The Med1 subunit of the yeast mediator complex is involved in both transcriptional activation and repression PNAS, January 19, 1999; 96(2): 376 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gustafsson, L. C. Myers, J. Beve, H. Spahr, M. Lui, H. Erdjument-Bromage, P. Tempst, and R. D. Kornberg Identification of New Mediator Subunits in the RNA Polymerase II Holoenzyme from Saccharomyces cerevisiae J. Biol. Chem., November 20, 1998; 273(47): 30851 - 30854. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Myer and R. A. Young RNA Polymerase II Holoenzymes and Subcomplexes J. Biol. Chem., October 23, 1998; 273(43): 27757 - 27760. [Full Text] [PDF] |
||||
![]() |
H. Cho, G. Orphanides, X. Sun, X.-J. Yang, V. Ogryzko, E. Lees, Y. Nakatani, and D. Reinberg A Human RNA Polymerase II Complex Containing Factors That Modify Chromatin Structure Mol. Cell. Biol., September 1, 1998; 18(9): 5355 - 5363. [Abstract] [Full Text] |
||||
![]() |
Y. C. Lee and Y.-J. Kim Requirement for a Functional Interaction between Mediator Components Med6 and Srb4 in RNA Polymerase II Transcription Mol. Cell. Biol., September 1, 1998; 18(9): 5364 - 5370. [Abstract] [Full Text] |
||||
![]() |
H. Friesen, J. C. Tanny, and J. Segall SPE3, Which Encodes Spermidine Synthase, Is Required for Full Repression Through NREDIT in Saccharomyces cerevisiae Genetics, September 1, 1998; 150(1): 59 - 73. [Abstract] [Full Text] |
||||
![]() |
R. K. Tabtiang and I. Herskowitz Nuclear Proteins Nut1p and Nut2p Cooperate To Negatively Regulate a Swi4p-Dependent lacZ Reporter Gene in Saccharomyces cerevisiae Mol. Cell. Biol., August 1, 1998; 18(8): 4707 - 4718. [Abstract] [Full Text] |
||||
![]() |
J. M. Gancedo Yeast Carbon Catabolite Repression Microbiol. Mol. Biol. Rev., June 1, 1998; 62(2): 334 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hampsey Molecular Genetics of the RNA Polymerase II General Transcriptional Machinery Microbiol. Mol. Biol. Rev., June 1, 1998; 62(2): 465 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakurai and T. Fukasawa Functional Correlation among Gal11, Transcription Factor (TF) IIE, and TFIIH in Saccharomyces cerevisiae. Gal11 AND TFIIE COOPERATIVELY ENHANCE TFIIH-MEDIATED PHOSPHORYLATION OF RNA POLYMERASE II CARBOXYL-TERMINAL DOMAIN SEQUENCES J. Biol. Chem., April 17, 1998; 273(16): 9534 - 9538. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kuchin and M. Carlson Functional Relationships of Srb10-Srb11 Kinase, Carboxy-Terminal Domain Kinase CTDK-I, and Transcriptional Corepressor Ssn6-Tup1 Mol. Cell. Biol., March 1, 1998; 18(3): 1163 - 1171. [Abstract] [Full Text] |
||||
![]() |
L. C. Myers, C. M. Gustafsson, D. A. Bushnell, M. Lui, H. Erdjument-Bromage, P. Tempst, and R. D. Kornberg The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain Genes & Dev., January 1, 1998; 12(1): 45 - 54. [Abstract] [Full Text] |
||||
![]() |
H. Sakurai and T. Fukasawa Yeast Gal11 and Transcription Factor IIE Function through a Common Pathway in Transcriptional Regulation J. Biol. Chem., December 19, 1997; 272(51): 32663 - 32669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Svejstrup, Y. Li, J. Fellows, A. Gnatt, S. Bjorklund, and R. D. Kornberg Evidence for a mediator cycle at the initiation of transcription PNAS, June 10, 1997; 94(12): 6075 - 6078. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |